{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:09:59Z","timestamp":1778548199939,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.mehy.2014.06.012","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T23:02:57Z","timestamp":1403218977000},"page":"355-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Are all placebo respondents non-smokers?"],"prefix":"10.1016","volume":"83","author":[{"given":"Paul","family":"Enck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle","family":"Klosterhalfen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2014.06.012_b0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3923","article-title":"The placebo response in medicine: minimize, maximize or personalize?","volume":"12","author":"Enck","year":"2013","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.mehy.2014.06.012_b0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.2013.283787","article-title":"Pharmacological treatments for smoking cessation","volume":"311","author":"Cahill","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2014.06.012_b0015","first-page":"CD009329","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"5","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mehy.2014.06.012_b0020","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","volume":"1","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mehy.2014.06.012_b0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1037\/a0031833","article-title":"Nicotine stimulus expectancy differentially affects reaction time in healthy nonsmokers and smokers depending on sex: a pilot study","volume":"21","author":"Weimer","year":"2013","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.mehy.2014.06.012_b0030","first-page":"A115","article-title":"Nicotine stimulus expectancy but not nicotine affects cognitive performance in healthy smokers and non-smokers","volume":"75","author":"Weimer","year":"2013","journal-title":"Psychosom Med"},{"key":"10.1016\/j.mehy.2014.06.012_b0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1572-0241.2006.01183.x","article-title":"STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo controlled double-blind study","volume":"102","author":"von Arnim","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mehy.2014.06.012_b0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2982.2008.01241.x","article-title":"The placebo response in functional dyspepsia - reanalysis of trial data","volume":"21","author":"Enck","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.mehy.2014.06.012_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MEG.0b013e32834bb951","article-title":"Placebo responses and placebo effects in functional bowel disorders","volume":"24","author":"Enck","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mehy.2014.06.012_b0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/ijerph9010192","article-title":"Do placebo response rates from cessation trials inform on strength of addictions?","volume":"9","author":"Moore","year":"2012","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.mehy.2014.06.012_b0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archgenpsychiatry.2010.88","article-title":"Effects of expectation on placebo-induced dopamine release in Parkinson disease","volume":"67","author":"Lidstone","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2014.06.012_b0060","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.biopsych.2007.09.015","article-title":"A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence","volume":"63","author":"Barr","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2014.06.012_b0065","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1046\/j.1460-9568.2001.02009.x","article-title":"Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections","volume":"15","author":"Ferrari","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2014.06.012_b0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1749-6632.2009.04424.x","article-title":"Neurobiological mechanisms of placebo responses","volume":"1156","author":"Zubieta","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.mehy.2014.06.012_b0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-1781(01)00332-8","article-title":"Dopaminergic augmentation of sleep deprivation effects in bipolar depression","volume":"104","author":"Benedetti","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.mehy.2014.06.012_b0080","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1077349","article-title":"Discrete coding of reward probability and uncertainty by dopamine neurons","volume":"299","author":"Fiorillo","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.mehy.2014.06.012_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","article-title":"Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD","volume":"19","author":"Papakostas","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2014.06.012_b0090","first-page":"53","article-title":"Signal detection and placebo response in schizophrenia: parallels with depression","volume":"43","author":"Mallinckrodt","year":"2010","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.mehy.2014.06.012_b0095","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00213-004-1824-8","article-title":"Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence","volume":"175","author":"Smolka","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.mehy.2014.06.012_b0100","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1523\/JNEUROSCI.2534-08.2008","article-title":"A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety","volume":"28","author":"Furmark","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2014.06.012_b0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/JCP.0b013e3181ac4aaf","article-title":"Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder","volume":"29","author":"Leuchter","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.mehy.2014.06.012_b0110","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1017\/S1461145712000843","article-title":"Analysis of 34 candidate genes in bupropion and placebo remission","volume":"16","author":"Tiwari","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2014.06.012_b0115","doi-asserted-by":"crossref","first-page":"e48135","DOI":"10.1371\/journal.pone.0048135","article-title":"Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome","volume":"7","author":"Hall","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2014.06.012_b0120","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/add.12325","article-title":"Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion","volume":"108","author":"David","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.mehy.2014.06.012_b0125","doi-asserted-by":"crossref","first-page":"562393","DOI":"10.1155\/2012\/562393","article-title":"Functional dyspepsia: subtypes, risk factors, and overlap with irritable bowel syndrome in a population of African patients","volume":"2012","author":"Nwokediuko","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.mehy.2014.06.012_b0130","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2169\/internalmedicine.50.6012","article-title":"Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome","volume":"50","author":"Fujiwara","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.mehy.2014.06.012_b0135","doi-asserted-by":"crossref","unstructured":"Parkes GC, Whelan K, Lindsay JO. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 2014 [in press]. doi: http:\/\/dx.doi.org\/10.1016\/j.crohns.2014.02.002.","DOI":"10.1016\/j.crohns.2014.02.002"},{"key":"10.1016\/j.mehy.2014.06.012_b0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2014.06.012_b0145","doi-asserted-by":"crossref","unstructured":"Ahlers E, Hahn E, Ta TM, Goudarzi E, Dettling M, Neuhaus AH. Smoking improves divided attention in schizophrenia. Psychopharmacology (Berl) 2014 [in press].","DOI":"10.1007\/s00213-014-3525-2"},{"key":"10.1016\/j.mehy.2014.06.012_b0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.15288\/jsad.2014.75.211","article-title":"ADHD symptoms, autistic traits, and substance use and misuse in adult Australian twins","volume":"75","author":"De Alwis","year":"2014","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.mehy.2014.06.012_b0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/JAD-2002-4407","article-title":"The nicotinic acetylcholine receptor, smoking, and Alzheimer\u2019s disease","volume":"4","author":"Sabbagh","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.mehy.2014.06.012_b0160","first-page":"MS54","article-title":"Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries","volume":"11","author":"Fricchione","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.mehy.2014.06.012_b0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2982.2009.01285.x","article-title":"The story of O \u2013 is oxytocin the mediator of the placebo response?","volume":"21","author":"Enck","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.mehy.2014.06.012_b0170","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/jama.2013.277446","article-title":"Effect of oxytocin on placebo analgesia: a randomized study","volume":"310","author":"Kessner","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2014.06.012_b0175","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm.2435","article-title":"Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors","volume":"17","author":"Benedetti","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2014.06.012_b0180","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/mp.2012.195","article-title":"Sharing pain and relief: neural correlates of physicians during treatment of patients","volume":"19","author":"Jensen","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2014.06.012_b0185","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1136\/amiajnl-2012-001257","article-title":"Creation and implementation of a historical controls database from randomized clinical trials","volume":"20","author":"Desai","year":"2013","journal-title":"J Am Med Inform Assoc"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714002473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714002473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T15:08:45Z","timestamp":1565536125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0306987714002473"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.06.012","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are all placebo respondents non-smokers?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}